Thursday, July 6, 2023

Antisense therapy restores fragile X protein production in human cells

An antisense therapy restores production of the protein FMRP in cell samples taken from patients with fragile X syndrome. This breakthrough was possible because of the novel findings, also presented in the study, that aberrant alternative splicing of messenger RNA (mRNA) plays a principal role in fragile X syndrome, the most common form of inherited intellectual disability and the most frequent single-gene cause of autism.

from Top Health News -- ScienceDaily https://ift.tt/koNZVm3

No comments:

Post a Comment

New fentanyl vaccine blocks deadly overdoses before they start

A new experimental vaccine developed by Scripps Research could offer a powerful new way to prevent fentanyl overdoses by stopping the drug b...